BioUtah News
-
Multi-Center Liquid Embolic Study Concludes
Completion of Trial is a Sign of Things to Come for Novel Embolic Agent
-
BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay
FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global…
-
BioHive Women in STEM Event recap
BioHive continued its celebration of “STEM September” with the Women in STEM Mingle in downtown Salt Lake City…
-
2022 Biosphere Magazine Now Available
Each year, BioUtah publishes a special Utah life sciences magazine, Biosphere, released with the September issue of Utah Business…
-
Excess Equipment Sale for BioUtah Members
Excess Equipment Sale for BioUtah Members
-
FDA Clears Xenocor’s Saberscope, the World’s First Single-use 5mm Laparoscope with Auto-Focus
FDA Clears World’s First Single-use 5mm Laparoscope with Auto-Focus
-
Merit Medical Launches the TEMNO Elite™ Soft Tissue Biopsy System
Advanced device offers 72% larger samples, simplifies tissue retrieval, and enhances patient safety
-
AAV5 DetectCDx™ Kit Is First ARUP Test Developed to Support a New Therapy
The European Commission’s approval of a novel gene therapy for severe hemophilia A has paved the way for…
-
Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Business Highlights
Dynatronics reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an…
-
Recruitment for Non-Invasive Parkinson’s Pivotal Study Slated for December
Non-invasive Parkinson’s therapeutic device moves one step closer to FDA clearance, with important potential non-motor and motor improvements…
-
nView s1 reaches its 100th surgery
The nView s1 has just surpassed its landmark 100th clinical case with the help of 22 surgeons at…
-
EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL
Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards’ breakthrough RESILIA tissue…
-
Inherent Biosciences raises Series A funding led by Propel Bio Partners to redefine the path to parenthood by elevating the standard of care in male reproductive health
Salt Lake City, Utah /PRNewswire/ — Inherent Biosciences, the first Utah company involved in commercializing a diagnostic in…
-
BIOHIVE STEM SEPTEMBER KICK-0FF
Last week, BioHive kicked off its celebration of “STEM September” with an evening of networking in downtown Salt…
-
Rep. Burgess Owens Spends a Day in the BioHive
Utah life sciences companies took center stage September 2, as U.S. Representative Burgess Owens (R-UT) toured Canyon Labs,…
-
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and…
-
Senator Mike Lee Spends a Day in the BioHive
U.S. Senator Mike Lee (R-UT) on August 15 spent the day connecting with Utah’s life sciences community, known…
-
Halia Therapeutics Promotes Targeting the NLRP3 Inflammasome for Alzheimer’s Disease Treatment
Halia Therapeutics, the first biotechnology company to target NEK7 to block the assembly of the NLRP3 inflammasome complex,…
-
Renalytix Business Update
Based on recently secured private payer and Medicaid insurance coverage contracts for KidneyIntelX, Renalytix plc is disclosing that…
-
Nomi Health Adds Access to Novavax COVID Vaccine in Utah
Nomi Health, a direct healthcare company dedicated to improving access and lowering costs in the healthcare system, has…
-
Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform Granted by the U.S. Patent Office
Transit Scientific, a Utah-based medical device company, today announced additional U.S. patent protection has been issued from the United States Patent…
-
Senate Passes Inflation Reduction Act – Sens. Lee, Romney Oppose
After an all-night session, the Senate on Sunday passed a sweeping, $740 billion reconciliation package titled the “Inflation…
-
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care Physicians
98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult…
-
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia
Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics has announced the U.S. Food and…
-
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update
PolarityTE provided a business update and reported financial results for the quarterly period ended June 30, 2022.
-
Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platform
-
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336.
-
New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models
Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses
-
Merit Medical Launches SafeGuard Focus Cool™ Compression Device
Modern design advances patient care by combining hemostasis with innovative cooling capability
-
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelXTM with Primary Care Physicians
98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult…
-
Soft Cell Labs announces new Urinary Tract Infection Test
Soft Cell Labs announces new Urinary Tract Infection Test
-
ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories
ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of…
-
bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®
bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®
-
3M Announces Plans to Create Long Term Value Through Spin-Off of Health Care Business
New 3M will remain a leading global material science innovator serving diverse end markets, with science and technology,…
-
Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality
Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality
-
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022
UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in…
-
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-0390, an Investigational Emopamil-binding Protein (EBP) Inhibitor for the Treatment of Brain Cancer
Sumitomo Pharma Oncology recently announced the U.S. FDA granted Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein…
-
Forbes Magazine Recognizes ARUP Among Nation’s Best Employers for Women
ARUP Laboratories’ ongoing commitment to provide an environment of diversity, inclusion, and belonging for all employees has earned…
-
Published UCLA and Spectrum Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers
Spectrum Solutions announced the publishing of findings from their research collaboration with the University of California at Los…
-
Clene’s ALS Drug Increases Survival by 70% in Mid-stage Study
Shares of Clene, Inc. surged Thursday after the company released “golden” data from an interim analysis of a…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
